Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies

J Tie, J Desai - Targeted oncology, 2015 - Springer
… focused on targeting BRAF as an … and clinical features of BRAF mutant colorectal cancer,
the prognostic and predictive role of BRAFV600E mutation in colorectal cancer, initial clinical

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications

KT Tang, CH Lee - Journal of the chinese medical association, 2010 - journals.lww.com
… of PTC, and the clinical implications of BRAFV600E mutation in the diagnosis, prognosis …
its clinical implications.In this article, we review the mechanism of BRAFV600E mutation and …

[HTML][HTML] BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications

V Angerilli, G Sabella, G Centonze, S Lonardi… - Critical Reviews in …, 2022 - Elsevier
… On these bases, BRAF mutational testing is now … are needed to further stratify patients
carrying this mutation. … -V600E BRAF mutations, which accounts for 22% of all BRAF

[HTML][HTML] BRAF-mutated colorectal cancer: clinical and molecular insights

F Caputo, C Santini, C Bardasi, K Cerma… - International journal of …, 2019 - mdpi.com
… of BRAF mutations has emerged. … on BRAF mutation status: BRAF V600E- and non-V600-mutated
CRC [13]. These two molecular subtypes of CRC are characterized by distinct clinical

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications

CE Bond, VLJ Whitehall - Gastroenterology research and …, 2018 - Wiley Online Library
… the BRAF mutation in terms of prognostic and clinical implications, and although this
mutation occurs in varied genetic backgrounds, its presence can influence clinical practice and …

[HTML][HTML] Clinical implications of BRAF mutation test in colorectal cancer

EN Mojarad, RK Farahani, MM Haghighi… - … and Hepatology from …, 2013 - ncbi.nlm.nih.gov
… to do clinical studies on the correlation between BRAF mutation and … BRAF should be
considered. We propose studies in CRC in Iran on the clinical impact of KRAS and BRAF mutation, …

BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine reviews, 2007 - academic.oup.com
… of BRAF mutation with the clinical progression, recurrence, and treatment failure of PTC has
also been demonstrated. The BRAF mutation has … mechanisms determining BRAF mutation-…

Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implications

AJ De Langen, EF Smit - Therapeutic Advances in Medical …, 2017 - journals.sagepub.com
… of most non-V600E BRAF mutations is increased compared with WT BRAF receptor activity,
but some BRAF mutations are kinase-dead or have lower activity than WT BRAF [Wan et al. …

BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications

F Sclafani, G Gullo, K Sheahan, J Crown - Critical reviews in oncology …, 2013 - Elsevier
… role of BRAF mutations in melanoma and colorectal cancer, focusing on similarities and
differences of BRAF mutations with respect to frequency, demographics, risk factors, mutation-…

[HTML][HTML] Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations

L Heinzerling, M Baiter, S Kühnapfel, G Schuler… - British journal of …, 2013 - nature.com
… of rare V600 BRAF mutations in primary tumours and different metastases of melanoma
patients, compares different detection methods, and correlates the BRAF genotype with clinical